Role of the fibroblast growth factor 19 in the skeletal system

被引:30
|
作者
Chen, Hao [1 ]
Li, Jiazhou [1 ]
Zhang, Demao [1 ]
Zhou, Xuedong [1 ,2 ]
Xie, Jing [1 ]
机构
[1] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp Stornatol, Dept Cariol & Endodont, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
Fibroblast growth factorl9; Fibroblast growth factor receptor; Skeletal development; Skeletal diseases; FACTOR RECEPTOR; BILE-ACID; IN-VIVO; 3-DIMENSIONAL STRUCTURE; STRUCTURAL BASIS; MOLECULAR-BASIS; BONE-GROWTH; FGF FAMILY; EXPRESSION; PROTEIN;
D O I
10.1016/j.lfs.2020.118804
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Fibroblast growth factor family (FGFs) is a kind of cytokine that plays an important role in growth, development, metabolism and disease. During bone development, multiple FGFs and fibroblast growth factor receptors (FGFRs) play important roles. Previous reports have elucidated the great importance of FGF1, 2, 4, 6, 7, 8, 9, 10, and 18 in bone development, and FGF21 and 23 in bone homeostasis and bone regulation. FGF19 was initially found in the human foetal brain, and its gene location is related to osteoporosis pseudoglioma syndrome. Presently, gene chip detection has repeatedly found that FGF19 shows spatiotemporal specificity of gene expression in bone development and bone-related diseases, as well as differences in the protein level, indicating that FGF19 affects the skeletal system. Considering the current insufficient understanding of FGF19 and its potential function in the skeletal system, this review aims to introduce the background of FGF19 in bone, summarise the research progress of FGF19 in the skeletal system, and discuss the role and therapeutic potential of FGF19 in bone development and bone-related diseases.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Skeletal actions of fibroblast growth factor-8 in vitro
    Lin, J. M.
    Callon, K. E.
    Lin, J. S.
    Watson, M.
    Empson, V.
    Grey, A.
    Naot, D.
    Green, C. R.
    Reid, I. R.
    Cornish, J.
    BONE, 2009, 44 : S135 - S135
  • [22] Skeletal disorders associated with fibroblast growth factor receptor mutations
    DeMoerlooze, L
    Dickson, C
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 1997, 7 (03) : 378 - 385
  • [23] Craniosynostosis and skeletal dysplasias: Fibroblast growth factor receptor defects
    Lewanda, AF
    Meyer, GA
    Jabs, EW
    PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1996, 108 (01) : 19 - 24
  • [24] The Role of Fibroblast Growth Factor 19 Subfamily in Different Populations Suffering From Osteoporosis
    Yu, Xiawen
    Xia, Yue
    Jia, Jue
    Yuan, Guoyue
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [25] Regulation of skeletal myogenesis by a secreted fibroblast growth factor receptor
    Bernard, DW
    Scata, KA
    Fox, JC
    Swain, JL
    CIRCULATION, 1996, 94 (08) : 2071 - 2071
  • [26] The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system
    Grothe, Claudia
    Timmer, Marco
    BRAIN RESEARCH REVIEWS, 2007, 54 (01) : 80 - 91
  • [27] The Role of Fibroblast Growth Factor Signaling in Somitogenesis
    Chandel, Angad Singh
    Stocker, Matthew
    Ozbudak, Ertugrul M.
    DNA AND CELL BIOLOGY, 2023, 42 (10) : 580 - 584
  • [28] The role of fibroblast growth factor 21 in atherosclerosis
    Kokkinos, John
    Tang, Shudi
    Rye, Kerry-Anne
    Ong, Kwok Leung
    ATHEROSCLEROSIS, 2017, 257 : 259 - 265
  • [29] Metabolic Messengers: fibroblast growth factor 15/19
    Raffaella Maria Gadaleta
    Antonio Moschetta
    Nature Metabolism, 2019, 1 : 588 - 594
  • [30] Metabolic Messengers: fibroblast growth factor 15/19
    Gadaleta, Raffaella Maria
    Moschetta, Antonio
    NATURE METABOLISM, 2019, 1 (06) : 588 - 594